Surmodics reported $29.39M in Current Liabilities for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Align Technology ALGN:US $ 1804.41M 59.23M
Anika Therapeutics ANIK:US $ 29.43M 2.44M
Arrowhead Research ARWR:US $ 128.21M 10.64M
Baxter International BAX:US $ 3916M 26M
Bioscrip BIOS:US $ 555.31M 47.17M
Cryolife CRY:US $ 41.65M 1.19M
Edap Tms EDAP:US $ 16.22M 1.74M
Edwards Lifesciences EW:US $ 969.1M 19.2M
Haemonetics HAE:US $ 442.27M 86.86M
Heron Therapeutics HRTX:US $ 109.5M 16.5M
Merit Medical Systems MMSI:US $ 195.59M 8.24M
Mesa Laboratories MLAB:US $ 44.13M 3.93M
Nektar Therapeutics NKTR:US $ 104.98M 0.3M
Stryker SYK:US $ 4404M 4M
Surmodics SRDX:US $ 29.39M 1.02M
Trinity Biotech TRIB:US $ 15.94M 84.55M